Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.30%
adds when stocks drop
when a holding falls −10%+
Middle response
+2.72%
steady accumulation
Rally response
-0.14%
trims into rallies
when a holding rises +10%+
Top positions · 5
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| MNSTMonster Beverage Corpora | $587M | 52.6% | +23.8% | 10.5 yr |
| AXONAxon Enterprise, Inc. | $295M | 26.4% | -19.3% | 8.5 yr |
| IWMiShares Russell 2000 ETF | $118M | 10.5% | — | 10.5 yr |
| LCTXLineage Cell Therapeutic | $78M | 7.0% | +249.9% | 6.8 yr |
| IMDXInsight Molecular Diagno | $39M | 3.5% | +7.2% | 2.8 yr |
Portfolio composition (YoY)
Industry mix
Beverages - Non-Alcoholic52.6%+4.7pp$587M
Aerospace & Defense26.4%-9.7pp$295M
Asset Management10.5%+1.2pp$118M
Biotechnology7.0%+4.8pp$78M
Medical - Diagnostics & Research3.5%+0.1pp$39M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| MNST | $485M | +0.12B | 23.8% |
| LCTX | $22M | +0.06B | 249.9% |
| IMDX | $35M | +0.00B | 7.2% |
| AXON | $366M | -0.07B | -19.3% |
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| AXON | $366M | -0.07B | -19.3% |
Top buys this quarter · 1
| IMDX Insight Molecular Diagnostics | +$39M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.12B | 5 | +11.30% | +17.59% | -6.30% | +0.01B |
| 2025-12-31 | $1.31B | 6 | +32.28% | +17.72% | +14.56% | -0.00B |
| 2025-09-30 | $1.29B | 6 | +51.86% | +17.52% | +34.34% | -0.02B |
| 2025-06-30 | $1.31B | 7 | +71.78% | +14.94% | +56.84% | -0.00B |
| 2025-03-31 | $1.01B | 7 | +14.24% | +8.30% | +5.94% | -0.00B |
| 2024-12-31 | $1.02B | 6 | +24.94% | +24.89% | +0.06% | -0.04B |
| 2024-09-30 | $904M | 6 | +20.20% | +36.04% | -15.83% | -0.02B |
| 2024-06-30 | $810M | 6 | -1.10% | +24.49% | -25.60% | +0.02B |
| 2024-03-31 | $919M | 6 | +15.98% | +29.62% | -13.65% | -0.01B |
| 2023-12-31 | $844M | 6 | +24.52% | +26.18% | -1.66% | -0.00B |
| 2023-09-30 | $753M | 6 | +35.56% | +21.57% | +13.99% | -0.07B |
| 2023-06-30 | $876M | 6 | +40.08% | +19.42% | +20.66% | +0.01B |
| 2023-03-31 | $860M | 6 | +37.82% | -7.82% | +45.64% | -0.05B |
| 2022-12-31 | $769M | 6 | +22.26% | +7.56% | +14.70% | -0.09B |
| 2022-09-30 | $704M | 7 | -3.49% | -4.93% | +1.44% | +0.01B |
| 2022-06-30 | $717M | 7 | -0.77% | -16.11% | +15.34% | +0.02B |